CGT Oxygen Therapy for Sickle Cell | Top Suppliers Like Thermo Fisher
Our CGT Oxygen Therapy is a breakthrough treatment for patients with Sickle Cell Disease, developed by T&L Biotechnology Co., Ltd. Our therapy utilizes the power of gene editing and oxygenation to provide long-term relief for individuals suffering from this debilitating condition, Sickle Cell Disease is a genetic disorder that causes the production of abnormal hemoglobin, leading to red blood cells that are sickle-shaped and prone to clogging blood vessels. Our CGT Oxygen Therapy works by targeting the genetic mutations responsible for the abnormal hemoglobin production, effectively correcting the root cause of the disease. Additionally, the therapy enhances the oxygen-carrying capacity of red blood cells, reducing the risk of complications such as pain crises and organ damage
